Clinical trial
A Study of Chidamide With AZA in MRD Positive AML After Transplant
NCT06066905 is registered in ClinicalTrials.gov with Guangdong Provincial People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study of Chidamide With AZA in MRD Positive AML After Transplant
- Lead sponsor
- Guangdong Provincial People's Hospital
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- October 26, 2023
- Completion date
- December 31, 2026
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
aml, adult, minimal residual disease